Versatile, fast and reliable SARS-CoV-2 antibody assay

During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies—either through infection or vaccination. ...

'Nanobodies' could hold clues to new COVID-19 therapies

WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19.

Chromatin regulation enables generation of diverse antibodies

We need a variety of antibody types to help fight off invading foreign pathogens and our genome is exquisitely tuned to produce them to meet emerging needs. A new study finds that not just our DNA, but its configuration and ...

A step toward a universal flu vaccine

Each year, the flu vaccine has to be redesigned to account for mutations that the virus accumulates, and even then, the vaccine is often not fully protective for everyone.

page 3 from 11